Cancer in multiple sclerosis patients following prolonged exposure to disease-modifying therapies (DMTs): a systematic review and meta-analysis

被引：0
|
作者：
Vasileios Giannopapas [1 ]
Vassiliki Smyrni [2 ]
Dimitrios K. Kitsos [1 ]
Maria Ioanna Stefanou [1 ]
Aikaterini Theodorou [1 ]
John S. Tzartos [1 ]
Georgios Tsivgoulis [1 ]
Sotirios Giannopoulos [1 ]
机构：
[1] National & Kapodistrian University of Athens,Second Department of Neurology, Attikon University Hospital
[2] University of West Attica,Department of Physical Therapy
来源：
Journal of Neurology | 2025年 / 272卷 / 2期
关键词：
Multiple sclerosis; Autoimmune diseases; Cancer; Malignancy; Disease-modifying therapies;
D O I：
10.1007/s00415-024-12882-4
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis
    Sriwastava, Shitiz
    Kataria, Saurabh
    Srivastava, Samiksha
    Kazemlou, Shaghayegh
    Gao, Si
    Wen, Sijin
    Saber, Hamidreza
    Tripathi, Richa
    Sheikh, Zubeda
    Peterson, Sarah
    Gwinn, Ronald
    Bernitsas, Evanthia
    JOURNAL OF NEUROIMMUNOLOGY, 2021, 360
  • [2] Disease-modifying therapies and T1 hypointense lesions in patients with multiple sclerosis: A systematic review and meta-analysis
    Valizadeh, Amir
    Fattahi, Mohammad Reza
    Sadeghi, Maryam
    Torbati, Mehrnush Saghab
    Sahraian, Mohammad Ali
    Azimi, Amir Reza
    CNS NEUROSCIENCE & THERAPEUTICS, 2022, 28 (05) : 648 - 657
  • [3] Comparative efficacy and safety of disease-modifying therapies in patients with relapsing multiple sclerosis: A systematic review and network meta-analysis
    Chen, Chaoyang
    Zhang, Enyao
    Zhu, Chunsu
    Wei, Ran
    Ma, Lingyun
    Dong, Xiu
    Li, Ruoming
    Sun, Feng
    Zhou, Ying
    Cui, Yimin
    Liu, Zhenming
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2023, 63 (01) : 8 - +
  • [4] Comparative efficacy of disease-modifying therapies for patients with relapsing remitting multiple sclerosis: Systematic review and network meta-analysis
    Fogarty, Emer
    Schmitz, Susanne
    Tubridy, Niall
    Walsh, Cathal
    Barry, Michael
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2016, 9 : 23 - 30
  • [5] Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing–remitting multiple sclerosis: a systematic review and network meta-analysis
    Huihui Li
    Fengli Hu
    Yanli Zhang
    Kai Li
    Journal of Neurology, 2020, 267 : 3489 - 3498
  • [6] Response of COVID-19 vaccination in multiple sclerosis patients following disease-modifying therapies: A meta-analysis
    Wu, Xi
    Wang, Lu
    Shen, Lu
    Tang, Kefu
    EBIOMEDICINE, 2022, 81
  • [7] Role of disease-modifying oral drugs in multiple sclerosis: A systematic review with meta-analysis
    Lopez-Ruiz, Minerva
    Guzman-Vazquez, Silvia
    Diaz-Alvarez, Osvaldo
    Buendia-Lopez, Yareli O.
    Soto-Molina, Herman
    REVISTA MEXICANA DE NEUROCIENCIA, 2021, 22 (01): : 30 - 39
  • [8] Disease-Modifying Therapies for Relapsing–Remitting Multiple Sclerosis: A Network Meta-Analysis
    Rosa C. Lucchetta
    Fernanda S. Tonin
    Helena H. L. Borba
    Letícia P. Leonart
    Vinicius L. Ferreira
    Aline F. Bonetti
    Bruno S. Riveros
    Jefferson Becker
    Roberto Pontarolo
    Fernando Fernandez-Llimós
    Astrid Wiens
    CNS Drugs, 2018, 32 : 813 - 826
  • [9] Impact of disease-modifying therapies on MRI outcomes in patients with relapsing-remitting multiple sclerosis: A systematic review and network meta-analysis
    Bose, Debdipta
    Ravi, Renju
    Maurya, Miteshkumar
    Pushparajan, Libby
    Konwar, Mahanjit
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 61
  • [10] Comparative efficacy and acceptability of disease-modifying therapies in patients with relapsing-remitting multiple sclerosis: a systematic review and network meta-analysis
    Li, Huihui
    Hu, Fengli
    Zhang, Yanli
    Li, Kai
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3489 - 3498
12345